Immunomodulatory Properties of Xylaria Nigripes in Peritoneal Macrophage Cells of Balb/c Mice
Overview
Affiliations
Ethnopharmacological Relevance: Wu Ling Shen, a folklore name for Xylaria nigripes (XN), is a high value medicinal fungus used in traditional Chinese medicine.
Aim Of Study: The present study aimed to examine the immunomodulatory properties of aqueous (XN-H) and ethanol (XN-E) XN extracts in lipopolysaccharide (LPS)-induced peritoneal macrophage cells of Balb/c mice.
Materials And Methods: After treating the macrophage cells with LPS (1 μg/ml) and different XN extracts, the immunomodulatory properties were determined by the responses of inflammatory mediators, namely nitrite oxide (NO), prostaglandin E2 (PGE(2)) and cytokine (IL-1β, IL-6, TNF-α and IFN-γ) production, iNOS, COX-2 and IκB-α expression, and NF-κB activation.
Results: Results showed that treatment of macrophages with 5-30 μg/ml of XN-H or XN-E plus 1 μg/ml LPS exhibited no cytotoxic effect on cell viability. At these concentrations, although both XN-H and XN-E showed a dose-dependent inhibitory effect on NO, PGE(2), IL-1β, IL-6, TNF-α and IFN-γ production in LPS-stimulated macrophages, a greater potency was noted in the XN-H treated group. RT-PCR assay also showed that XN-H possessed a greater inhibition than XN-E on iNOS and COX-2 RNA expression. Furthermore, XN-H also showed a significant stronger suppression than XN-E on the LPS-induced IκB-α phosphorylation and NF-κB activation. XN-E showed a higher total flavonoid and phenol contents but a lower β-glucan content than XN-H.
Conclusion: Taken together, these results conclude that XN-H possesses a stronger anti-inflammatory activity than XN-E, and its mechanism of action could be mediated by inhibiting iNOS and COX-2 expression via the NF-κB signaling pathway, and these activities could be contributed by the β-glucan content.
Bioactive Peptides and Other Immunomodulators of Mushroom Origin.
Drzewiecka B, Wessely-Szponder J, Swieca M, Espinal P, Fuste E, Fernandez-De La Cruz E Biomedicines. 2024; 12(7).
PMID: 39062056 PMC: 11274834. DOI: 10.3390/biomedicines12071483.
Spirocyclic derivatives as antioxidants: a review.
Acosta-Quiroga K, Rojas-Pena C, Nerio L, Gutierrez M, Polo-Cuadrado E RSC Adv. 2022; 11(36):21926-21954.
PMID: 35480788 PMC: 9034179. DOI: 10.1039/d1ra01170g.
Chopra H, Mishra A, Baig A, Mohanta T, Mohanta Y, Baek K J Fungi (Basel). 2021; 7(9).
PMID: 34575766 PMC: 8466349. DOI: 10.3390/jof7090728.
Watchaputi K, Somboon P, Phromma-In N, Ratanakhanokchai K, Soontorngun N Sci Rep. 2021; 11(1):7779.
PMID: 33833332 PMC: 8032726. DOI: 10.1038/s41598-021-87342-4.
The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy.
Peng W, Ding J, Wang X Curr Neuropharmacol. 2020; 19(8):1264-1272.
PMID: 33380304 PMC: 8719297. DOI: 10.2174/1570159X19666201230142716.